HRES 309
118th Congress
House
Health
Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.
Introduced: April 19, 2023
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 19, 2023
Referred to the House Committee on Energy and Commerce.
Apr 19, 2023
Introduced in House
Plain-English summary
This resolution expresses the sense of the House of Representatives that the Food and Drug Administration (FDA) has the authority to review and approve drugs pursuant to its own expertise, and that recent court decisions blocking the FDA's approval of mifepristone (which is used in medication abortion) violate congressional intent with respect to the FDA's authority.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1